| 3199 |
PMDT Treatment Book |
Live |
09/09/2022 |
| 3198 |
ART Centre of Excellence |
Live |
09/09/2022 |
| 3197 |
Link ART Centre |
Live |
09/09/2022 |
| 3196 |
ART Centre |
Live |
09/09/2022 |
| 3195 |
ICTC |
Live |
09/09/2022 |
| 3194 |
Interaction of DR-TB Coordinator with the TB Patient Care Ecosystem |
Live |
09/09/2022 |
| 3193 |
DR-TB HIV Coordinator and their role |
Live |
09/09/2022 |
| 3192 |
Referral mechanisms for DR-TB services |
Live |
09/09/2022 |
| 3191 |
PMDT structure and roles |
Live |
09/09/2022 |
| 354 |
Burden of DR-TB in India |
Live |
09/09/2022 |
| 1299 |
Biosafety measures required for Truenat |
Live |
08/09/2022 |
| 1372 |
Daily, Weekly and Monthly Maintenance of Truenat Instrument |
Live |
08/09/2022 |
| 1296 |
Maintenance of the Truenat Instrument - General Principles |
Live |
08/09/2022 |
| 1380 |
Ensuring Compliance of Truenat Instrument Installation Criteria |
Live |
08/09/2022 |
| 593 |
Drug-Resistant Tuberculosis(DR-TB) |
Live |
06/09/2022 |
| 1568 |
Management of M/XDR-TB Treatment During Pregnancy |
Pending Review |
06/09/2022 |
| 1859 |
Follow-up Monitoring of DR-TB Patients |
Pending Review |
06/09/2022 |
| 1093 |
Prevention of Drug-resistance |
Pending Review |
06/09/2022 |
| 1062 |
Causes for Drug-resistant Tuberculosis |
Pending Review |
06/09/2022 |
| 2620 |
Treatment of DR-TB in Children |
Pending Review |
06/09/2022 |
| 1234 |
Longer Oral M/XDR-TB: Regimen and Duration |
Pending Review |
06/09/2022 |
| 630 |
DR-TB Treatment Regimens |
Pending Review |
06/09/2022 |
| 1858 |
Key Considerations for the Use of Newer Drugs in DR-TB |
Pending Review |
06/09/2022 |
| 1064 |
Weight Band-wise Dosages of DR-TB Drugs for Adults |
Pending Review |
06/09/2022 |
| 1094 |
Shorter oral Bedaquiline-containing MDR/RR-TB regimen |
Live |
06/09/2022 |
| 1569 |
Counselling during DR-TB treatment |
Pending Review |
06/09/2022 |
| 1783 |
Palliative Care in DR-TB |
Pending Review |
06/09/2022 |
| 1848 |
District DR-TB Centre |
Pending Review |
06/09/2022 |
| 1847 |
Nodal DR-TB Centre |
Pending Review |
06/09/2022 |
| 1822 |
DR-TB Services and Functions of Stakeholders |
Pending Review |
06/09/2022 |
